ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Connecticut » Internal Medicine

Top Internal Medicine Prescribers in Connecticut

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSEPH BRENES M.D.

Internal Medicine

53,688

$3.49M

977
774 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 29%

$65
Average prescription price

Avg: $71

MARC RAAD M.D.

Internal Medicine

53,150

$3.71M

1186
884 are 65+

18%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $71

MARTIN PERLIN M.D.

Internal Medicine

47,668

$3.12M

1031
754 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 29%

$66
Average prescription price

Avg: $71

WAYNE PAULEKAS MD

Internal Medicine

32,513

$2.47M

748
540 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

2%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$76
Average prescription price

Avg: $71

JOHN HUANG M.D.

Internal Medicine

32,494

$2.63M

1400
1126 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$81
Average prescription price

Avg: $71

GARY MILLER MD

Internal Medicine

31,355

$2.26M

923
784 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$72
Average prescription price

Avg: $71

GILBERTO RAMIREZ MD

Internal Medicine

30,549

$2.03M

582
473 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 29%

$66
Average prescription price

Avg: $71

LEONARDI KOLIANI M.D.

Internal Medicine

26,378

$1.74M

881
681 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$66
Average prescription price

Avg: $71

DARSHAN SHAH M.D.

Internal Medicine

25,212

$1.52M

817
701 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$60
Average prescription price

Avg: $71

WAYNE LEVIN MD

Internal Medicine

25,112

$1.56M

804
730 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $71

DUSHYANT PARIKH M.D.

Internal Medicine

23,384

$1.71M

654
556 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 29%

$73
Average prescription price

Avg: $71

JOSEPH TOMANELLI M.D.

Internal Medicine

22,947

$1.6M

1097
961 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $71

SANTO BUCCHERI MD

Internal Medicine

22,451

$1.26M

675
596 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$56
Average prescription price

Avg: $71

CARLOS SCHWEITZER MD

Internal Medicine

21,937

$1.54M

755
612 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $71

PAUL MONACO M.D.

Internal Medicine

20,858

$1.2M

610
545 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$57
Average prescription price

Avg: $71

PANAYOTES YANNOPOULOS MD

Internal Medicine

19,227

$1.35M

574
451 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $71

STEPHEN YOELSON M.D.

Internal Medicine

18,883

$1.23M

672
526 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$65
Average prescription price

Avg: $71

STEPHEN ZEBROWSKI M.D.

Internal Medicine

18,745

$1.71M

597
467 are 65+

23%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$91
Average prescription price

Avg: $71

ADRIAN KLUFAS MD

Internal Medicine

18,286

$1.2M

555
305 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 29%

$65
Average prescription price

Avg: $71

ANDREA SCHAFFNER MD

Internal Medicine

18,194

$1.13M

679
646 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $71

JAMES BRUNETTI D.O.

Internal Medicine

17,874

$1.25M

909
827 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

2%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 29%

$70
Average prescription price

Avg: $71

PAUL DEUTSCH MD

Internal Medicine

17,739

$1.46M

896
751 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 29%

$83
Average prescription price

Avg: $71

DAVID DELUCIA MD

Internal Medicine

17,412

$1.21M

693
576 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 29%

$69
Average prescription price

Avg: $71

GEORGE DONAHUE MD

Internal Medicine

17,194

$981K

677
589 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 29%

$57
Average prescription price

Avg: $71

THERESA CAPUTO MD

Internal Medicine

17,077

$1.12M

892
766 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 29%

$66
Average prescription price

Avg: $71

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank